Urology Journal

Overview

publication venue for

• Concurrent Robotic Pyelolithotomy and Partial Nephrectomy: Tips and Tricks. 2018
• Precise Clamping of Renal Artery With Endovascular Stents During Robotic Partial Nephrectomy: Technical Hints to Optimize Outcomes. 2018
• Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer. 2012
• Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis. 2024
• Incidence, complications, and long-term outcomes of gender-affirming phalloplasty: analysis of a large statewide population-based dataset. 2024
• Gender-Based Disparity Exists in the Surgical Experience of Female and Male Urology Residents. 2024
• Author Reply to "Robotic-assisted Posterior Urethroplasty: Outcomes From 105 Men in a Single-center Experience". 2023
• Robotic-assisted posterior urethroplasty: outcomes from 105 men in a single-center experience. 2023
• Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should we revisit the goals of care? 2023
• Longitudinal Changes in the Operative Experience for Junior Urology Residents. 2023
• Adoption and Outcomes of HoLEP in the United States. 2023
• Comparison of postoperative outcomes of TURP, laser vaporization and laser enucleation: A Double Propensity Score Matched Analysis. 2023
• Current Practice Patterns in the Surgical Management of Benign Prostatic Hyperplasia. 2023
• Unilateral Scrotal Swelling: Diagnosis and Management. 2023
• Prosteria - National Trends and Outcomes of More Frequent Than Guideline Recommended Prostate Specific Antigen Screening..  174. 2023
• Trends in Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery from A Large National Cohort. 2022
• Effect of Surgeon and Facility Volume on Outcomes of Benign Prostatic Hyperplasia Surgery: Implications of Disparities in Access to Care at High-Volume Centers. 2022
• Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates. 2022
• Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation. 2022
• Predictors and trends of opioid-sparing radical prostatectomy from a large national cohort. 2022
• Microsurgical Excision of a Supernumerary Testis: A Novel Technique to Avoid Iatrogenic Injury to the Adjacent Testis. 2022
• The Lack of a Physical Exam During New Patient Telehealth Visits Does Not Impact Plans for Office and Operating Room Procedures..  167. 2022
• Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series..  167. 2022
• Medical Malpractice Lawsuits Involving Urology Trainees. 2022
• Longitudinal Changes in the Pelvic Pain Only and Widespread Pain Phenotypes Over One Year in the MAPP-I Urologic Chronic Pelvic Pain Syndrome (UCPPS) Cohort..  161. 2022
• Authorship Gender Composition in Urology Literature From 2015 Through 2020. 2022
• Consumption of a Healthy Plant-based Diet is Associated With a Decreased Risk of Erectile Dysfunction: A Cross-sectional Study of the National Health and Nutrition Examination Survey..  161. 2022
• The Future is Female: The Influence of Female Faculty and Resident Representation on Female Applicant Match Rate Amongst Urology Residency Programs Over 3 Years..  160. 2021
• Development and Usability Testing of a Mobile Application to Monitor Patient-Reported Outcomes after Stress Urinary Incontinence Surgery. 2021
• Noncancerous Genitourinary Conditions as a Public Health Priority: Conceptualizing the Hidden Burden. 2021
• Prostate Cancer Screening for Gay Men in the United States. 2021
• Impact of Plant-Based Diet on PSA Level: Data From the National Health and Nutrition Examination Survey..  156. 2021
• Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation..  155. 2021
• The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma..  154. 2021
• Influence of Department Leadership on Scholarly Productivity and Research Funding in Academic Urology..  154. 2021
• Epidemiology and Diagnosis of Erectile Dysfunction by Urologists Versus Non-Urologists in the United States: An Analysis of the National Ambulatory Medical Care Survey..  147. 2020
• Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis..  146. 2020
• Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma..  146. 2020
• Variations in Perioperative Antibiotic Prescriptions Among Academic Urologists After Ambulatory Endoscopic Urologic Surgery: Impact on Infection Rates and Validation of 2019 Best Practice Statement..  146. 2020
• RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors..  144. 2020
• Ejaculatory Hood-Sparing Vaporization of the Prostate and Its Impact on Erectile, Ejaculatory, and Sexual Function..  144. 2020
• Transvaginal Paravaginal Native Tissue Anterior Repair Technique: Initial Outcomes..  150. 2020
• Outpatient Extraperitoneal Single-Port Robotic Radical Prostatectomy..  144. 2020
• Patient-Reported Quality of Life and Convalescence After Minimally Invasive Kidney Cancer Surgery..  144. 2020
• The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment..  144. 2020
• Gender Bias in Medicine: Does It Exist at AUA Plenary Sessions?.  150. 2020
• Use of a Risk Stratification Tool to Guide Evaluation of Patients With Asymptomatic Microscopic Hematuria..  141. 2020
• Single-Port Percutaneous Transvesical Simple Prostatectomy Using the SP Robotic System: Initial Clinical Experience..  141. 2020
• Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma..  140. 2020
• Single-Port Robotic Urological Surgery Using Purpose-Built Single-Port Surgical System: Single-Institutional Experience With the First 100 Cases..  140. 2020
• Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members..  139. 2020
• Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation..  138. 2020
• Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States..  137. 2020
• Increased Risk of Hypogonadal Symptoms in Shift Workers With Shift Work Sleep Disorder..  138. 2020
• Risk Factors for Infection after Prostate Biopsy in the United States..  138. 2019
• Comparison of Urologic Transfers to Academic Medical Centers: A Multi-institutional Perspective..  136. 2019
• A Systematic Review and Evidence-based Analysis of Ingredients in Popular Male Fertility Supplements..  136. 2019
• A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy..  135. 2019
• Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy..  135. 2019
• Single Port Robotic Extra-peritoneal Dual Kidney Transplantation: Initial Preclinical Experience and Description of the Technique..  134. 2019
• Robot-assisted Laparoscopic Extravesical Cross-trigonal Ureteral Reimplantation With Tailoring for Primary Obstructive Megaureter..  134. 2019
• Upper Pole Access for Prone Percutaneous Nephrolithotomy: Advantage or Risk?.  134. 2019
• Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma..  134. 2019
• Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer..  131. 2019
• Single-port Robotic Intracorporeal Ileal Conduit Urinary Diversion During Radical Cystectomy Using the SP Surgical System: Step-by-step Technique..  130. 2019
• Distribution of Semen Parameters Among Adolescent Males Undergoing Fertility Preservation in a Multicenter International Cohort..  127. 2019
• Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study..  129. 2019
• Pure Single-Site Robot-Assisted Partial Nephrectomy Using the SP Surgical System: Initial Clinical Experience..  124. 2018
• Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study..  124. 2018
• Patient Decision-making and Predictors of Genital Satisfaction Associated With Testicular Prostheses After Radical Orchiectomy: A Questionnaire-based Study of Men With Germ Cell Tumors of the Testicle..  124. 2018
• An Infertile Couple's Long and Expensive Path to Varicocele Repair..  124. 2018
• Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria..  124. 2018
• Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience..  124. 2018
• Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device..  122. 2018
• Surgical Hints for Robot-Assisted Transvesical Simple Prostatectomy..  122. 2018
• Transperineal Approach for Intracorporeal Ileal Conduit Urinary Diversion Using a Purpose-built Single-port Robotic System: Step-by-step..  122. 2018
• Validation of a Simulation-training Model for Robotic Intracorporeal Bowel Anastomosis Using a Step-by-step Technique..  120. 2018
• Minimally Invasive Management of Ureteral Distal Strictures: Robotic Ureteroneocystostomy With a Bilateral Boari Flap..  120. 2018
• Robotic Partial Nephrectomy for Complex Hilar Tumors: Step by step..  120. 2018
• The Impact of Microsurgical Repair of Subclinical and Clinical Varicoceles on Total Motile Sperm Count: Is There a Difference?.  120. 2018
• Patient-specific Virtual Simulation-A State of the Art Approach to Teach Renal Tumor Localization..  120. 2018
• Infrared Light Structured Sensor Three-dimensional Approach to Estimate Kidney Volume: A Validation Study..  119. 2018
• Technique for Docking and Port Placement Using a Purpose-built Robotic System (SP1098) in Human Cadaver..  119. 2018
• Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor..  118. 2018
• Robotic Single-port Partial Prostatectomy for Anterior Tumors: Transvesical Approach..  118. 2018
• Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen..  114. 2018
• Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era..  111. 2017
• The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study..  111. 2017
• Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study..  109. 2017
• Scrotal Ultrasound for Pain: Low Frequency of Absolute Surgical Indications..  108. 2017
• Twitter Activity Associated With U.S. News and World Report Reputation Scores for Urology Departments..  108. 2017
• Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients..  106. 2017
• Malignant Mesothelioma of the Tunica Vaginalis Testis: Outcomes Following Surgical Management Beyond Radical Orchiectomy..  107. 2017
• From Galen's Urine to Harvey's Blood..  106. 2017
• The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education..  105. 2017
• Robot-assisted Laparoscopic Resection of Renal Vein Leiomyosarcoma..  103. 2017
• Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer..  102. 2017
• Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers..  102. 2016
• A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer..  102. 2016
• Vasectomy Reversal Surgical Patterns: An Analysis of the American Board of Urology Case Logs..  107. 2016
• Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy..  103. 2016
• Outcomes and Prognostic Factors of Primary Urethral Cancer..  100. 2016
• The Evolving Management of Patients With Clinical Stage I Seminoma..  98. 2016
• Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series..  98. 2016
• Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?.  98. 2016
• An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care..  96. 2016
• A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy..  96. 2016
• Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy..  95. 2016
• International Medical Graduate Training in Urology: Are We Missing an Opportunity?.  95. 2016
• Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes..  94. 2016
• Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience..  95. 2016
• Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract..  94. 2016
• Utilization of Preoperative Laboratory Testing for Low-risk, Ambulatory Urologic Procedures..  94. 2016
• Women in Urology Residency, 1978-2013: A Critical Look at Gender Representation in Our Specialty..  92. 2016
• Experienced Open vs Early Robotic-assisted Laparoscopic Radical Prostatectomy: A 10-year Prospective and Retrospective Comparison..  91. 2016
• Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation..  91. 2016
• Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men..  91. 2016
• Age, Body Mass Index, and Frequency of Sexual Activity are Independent Predictors of Testosterone Deficiency in Men With Erectile Dysfunction..  90. 2015
• Increased Body Mass Index in Men With Varicocele Is Associated With Larger Spermatic Vein Diameters When Supine..  89. 2015
• Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis..  88. 2015
• Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study..  89. 2015
• Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer..  87. 2015
• The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer..  86. 2015
• New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors..  86. 2015
• Trends in Mesh Use for Pelvic Organ Prolapse Repair From the Medicare Database..  86. 2015
• Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications..  86. 2015
• Revision Techniques After Artificial Urinary Sphincter Failure in Men: Results From a Multicenter Study..  86. 2015
• Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors..  85. 2015
• Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial..  85. 2015
• Four flawed arguments against prostate-specific antigen screening (and 1 good one)..  85. 2015
• A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration..  85. 2015
• Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease..  85. 2015
• Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients..  85. 2015
• Decision analysis of dutasteride use for patients with negative prostate biopsy..  85. 2015
• Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway..  85. 2015
• Evolution of laparoscopic donor nephrectomy technique and outcomes: a single-center experience with more than 1300 cases..  85. 2015
• Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form..  85. 2015
• Surgical competency for urethrovesical anastomosis during robot-assisted radical prostatectomy: development and validation of the robotic anastomosis competency evaluation..  85. 2015
• The fate of transitional urology patients referred to a tertiary transitional care center..  84. 2014
• Split-cuff nipple technique of ureteral reimplantation in children with thick-walled bladders due to posterior urethral valves..  85. 2014
• Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma..  84. 2014
• The role of ultrasonography in predicting vesicoureteral reflux..  84. 2014
• Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity..  84. 2014
• Who really benefits from nephron-sparing surgery?.  84. 2014
• Adult prostate sarcoma: the Memorial Sloan Kettering experience..  84. 2014
• Prostate size and adverse pathologic features in men undergoing radical prostatectomy..  84. 2014
• Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups..  84. 2014
• Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial..  84. 2014
• Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption..  83. 2014
• Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer..  83. 2014
• Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status..  84. 2014
• The impact of radical prostatectomy operative time on outcomes and costs..  83. 2014
• Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization..  83. 2014
• Clinicopathologic features of renomedullary interstitial cell tumor presenting as the main solid renal mass..  83. 2014
• Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy..  83. 2014
• Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens..  83. 2014
• The role of magnetic resonance imaging in delineating clinically significant prostate cancer..  83. 2014
• Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis..  83. 2014
• Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years..  82. 2013
• Translabial ultrasonography for evaluation of synthetic mesh in the vagina..  83. 2013
• 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters..  82. 2013
• Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American Urologists..  82. 2013
• Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy..  82. 2013
• A retrospective review of office-based 532-nm GreenLight laser prostatectomy in men with symptomatic benign prostatic hyperplasia..  82. 2013
• Effect of visceral obesity on minimally invasive partial nephrectomy..  82. 2013
• Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation..  82. 2013
• Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes..  82. 2013
• Management of anastomotic stricture after artificial urinary sphincter placement in patients who underwent salvage prostatectomy..  82. 2013
• Varicocelectomy is associated with increases in serum testosterone independent of clinical grade..  81. 2013
• Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy..  81. 2013
• Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma..  81. 2013
• Management of bladder cancer after renal transplantation..  81. 2013
• International variation in artificial urinary sphincter use..  80. 2012
• Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate..  80. 2012
• Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers..  80. 2012
• A modification to augmentation cystoplasty with catheterizable stoma for neurogenic patients: technique and long-term results..  80. 2012
• Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy..  80. 2012
• Pubovesical fistula: a rare complication after treatment of prostate cancer..  80. 2012
• Higher RENAL Nephrometry Score is predictive of longer warm ischemia time and collecting system entry during laparoscopic and robotic-assisted partial nephrectomy..  79. 2012
• Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy..  79. 2012
• Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy..  79. 2012
• Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy..  79. 2012
• Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site..  79. 2012
• Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer..  79. 2012
• Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder..  79. 2011
• We need a better marker for prostate cancer. How about renaming PSA?.  79. 2011
• Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection..  79. 2011
• Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy..  78. 2011
• New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches..  78. 2011
• The use of tissue expanders for resurfacing of the penis for hypospadias cripples..  78. 2011
• Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes..  78. 2011
• The effects of acute and chronic psychological stress on bladder function in a rodent model..  78. 2011
• Models to predict positive prostate biopsies using the Tyrol screening study..  78. 2011
• Ethnic differences in bladder cancer survival..  78. 2011
• Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy..  78. 2011
• Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis..  78. 2011
• Great meaningless questions in urology: which is better, open, laparoscopic, or robotic radical prostatectomy?.  77. 2011
• Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer..  77. 2011
• Simple, age-based formula for predicting renal length in children..  78. 2011
• Is right-sided laparoendoscopic single-site donor nephrectomy feasible?.  77. 2011
• Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update..  77. 2011
• Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder..  77. 2011
• Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer..  77. 2010
• Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma..  77. 2010
• Contemporary lymph node counts during primary retroperitoneal lymph node dissection..  77. 2010
• Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model..  77. 2010
• Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy..  76. 2010
• Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases..  76. 2010
• Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer..  76. 2010
• Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer..  76. 2010
• Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer..  77. 2010
• Misconceptions and miscommunication among aging women with overactive bladder symptoms..  77. 2010
• A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma..  76. 2010
• The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy..  76. 2010
• Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men..  77. 2010
• Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy..  76. 2010
• Does prior abdominal surgery influence outcomes or complications of robotic-assisted laparoscopic radical prostatectomy?.  76. 2010
• Predictors of inguinal hernia after radical prostatectomy..  77. 2010
• Ureteroileal anastomosis with intraluminal visualization: technique and outcomes..  76. 2010
• ERG rearrangement metastasis patterns in locally advanced prostate cancer..  75. 2010
• Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s)..  76. 2010
• The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer..  75. 2010
• Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience..  75. 2010
• Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality..  75. 2010
• Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients..  75. 2010
• Economic costs of overactive bladder in the United States..  75. 2009
• A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma..  75. 2009
• Critical evaluation of perioperative complications in laparoscopic partial nephrectomy..  75. 2009
• Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database..  75. 2009
• Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment..  75. 2009
• Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer..  74. 2009
• Why can't nomograms be more like Netflix?.  75. 2009
• A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma..  75. 2009
• Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries..  74. 2009
• Limited prognostic value of tumor necrosis in patients with renal cell carcinoma..  75. 2009
• Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI..  75. 2009
• Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?.  74. 2009
• Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist..  74. 2009
• A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States..  74. 2009
• Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer..  76. 2009
• The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer..  75. 2009
• Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors..  74. 2009
• Trends in surgical management of stress urinary incontinence among female Medicare beneficiaries..  74. 2009
• Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2..  73. 2009
• Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort..  73. 2009
• Urodynamic testing in evaluation of postradical prostatectomy incontinence before artificial urinary sphincter implantation..  73. 2009
• Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram..  73. 2009
• Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry..  73. 2009
• Antitumor effects of an imidazoquinoline in renal cell carcinoma..  73. 2009
• Conventional treatments of localized prostate cancer..  72. 2008
• Evaluating localized prostate cancer and identifying candidates for focal therapy..  72. 2008
• Focal therapy for prostate cancer: analysis by an international panel..  72. 2008
• New treatments for localized prostate cancer..  72. 2008
• Prostate cancer: epidemiology and health-related quality of life..  72. 2008
• Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma..  73. 2008
• Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection..  73. 2008
• Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer..  73. 2008
• Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience..  73. 2008
• Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study..  73. 2008
• Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires..  72. 2008
• Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study..  72. 2008
• Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer..  72. 2008
• A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer..  72. 2008
• Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy..  72. 2008
• Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer..  72. 2008
• Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy..  72. 2008
• Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer..  72. 2008
• Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy..  71. 2008
• Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery..  72. 2008
• Determinants of treatment regret in low-income, uninsured men with prostate cancer..  72. 2008
• Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy..  71. 2008
• Patient perceived outcomes of treatments used for interstitial cystitis..  71. 2008
• Prognostic significance of location of positive margins in radical prostatectomy specimens..  70. 2007
• Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder..  70. 2007
• Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer..  70. 2007
• Simultaneous vasectomy and varicocelectomy: indications and technique..  70. 2007
• Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy..  70. 2007
• Distinct patterns of endothelin axis expression in primary prostate cancer..  70. 2007
• Use of hydrophilic-coated urethral catheters in management of acute urinary retention..  70. 2007
• Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma..  69. 2007
• Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy..  69. 2007
• Tumor location does not affect long-term renal function after partial nephrectomy..  69. 2007
• Innovative single-armed suture technique for microsurgical vasoepididymostomy..  69. 2007
• Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm..  69. 2007
• Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients..  69. 2007
• Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma..  69. 2007
• Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract..  69. 2007
• Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer..  69. 2007
• Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder..  69. 2007
• Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure..  68. 2006
• Microsurgical inguinal varicocelectomy with and without testicular delivery..  68. 2006
• Perioperative clinical thromboembolic events after radical or partial nephrectomy..  68. 2006
• Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis..  68. 2006
• Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression..  68. 2006
• Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy..  68. 2006
• Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention..  68. 2006
• Percutaneous renal cryoablation..  68. 2006
• Complications after radical cystectomy: analysis of population-based data..  68. 2006
• Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation..  67. 2006
• The use of urine-based biomarkers in bladder cancer..  67. 2006
• True prevalence of urinary incontinence among female nursing home residents..  67. 2006
• Perineocele: symptom complex, description of anatomic defect, and surgical technique for repair..  67. 2006
• Extracorporeal shock wave lithotripsy monotherapy for treatment of patients with urethral and bladder stones presenting with acute urinary retention..  66. 2005
• Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?.  66. 2005
• Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients..  66. 2005
• Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome..  66. 2005
• Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")..  66. 2005
• Transvaginal paravaginal repair of high-grade cystocele central and lateral defects with concomitant suburethral sling: report of early results, outcomes, and patient satisfaction with a new technique..  66. 2005
• Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL..  66. 2005
• Early patient self-assessed outcomes of nerve-sparing radical perineal prostatectomy..  66. 2005
• Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy..  66. 2005
• Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi..  66. 2005
• Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy..  66. 2005
• Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma..  66. 2005
• Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer..  66. 2005
• In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats..  66. 2005
• Supplement use among men with prostate cancer..  66. 2005
• Anterior vaginal wall surgery in elderly patients: outcomes and assessment..  65. 2005
• Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population..  65. 2005
• Inheritance of varicoceles..  65. 2005
• Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction..  65. 2005
• Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen..  65. 2005
• Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies..  65. 2005
• Comparison of nephron-sparing surgery in central versus peripheral renal tumors..  65. 2005
• Impact of vaginal surgery for stress urinary incontinence on female sexual function: is the use of polypropylene mesh detrimental?.  65. 2005
• Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer..  65. 2005
• High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates..  64. 2004
• Botulinum toxin a has antinociceptive effects in treating interstitial cystitis..  64. 2004
• Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls..  64. 2004
• Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables..  64. 2004
• Intraoperative characterization of arterial vasculature in spermatic cord..  64. 2004
• Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer..  64. 2004
• Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer..  64. 2004
• Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy..  63. 2004
• Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy..  63. 2004
• Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer..  63. 2004
• Testosterone treatment of human foreskin in a novel transplant model..  63. 2004
• Evaluation of water jet morcellation as an alternative to hand morcellation of renal tissue ablation during laparoscopic nephrectomy: an in vitro study..  63. 2004
• Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease..  62 Suppl 1. 2003
• Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology..  62. 2003
• Dietary manipulation, ethnicity, and serum PSA levels..  62. 2003
• Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome..  62. 2003
• Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening..  62. 2003
• Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms..  62. 2003
• Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder..  61. 2003
• Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder..  61. 2003
• Long-term follow-up of bilateral sporadic renal tumors..  61. 2003
• Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results..  61. 2003
• Biochemical profile of stone-forming patients with diabetes mellitus..  61. 2003
• Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer..  61. 2003
• Cross-cultural validation of the UCLA prostate cancer index..  61. 2003
• Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial..  61. 2003
• Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy..  61. 2003
• Hand-assisted laparoscopy for large renal specimens: a multi-institutional study..  61. 2003
• High expression of the Met receptor in prostate cancer metastasis to bone..  60. 2002
• Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia..  60. 2002
• Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome..  60. 2002
• Impact of a second transurethral resection on the staging of T1 bladder cancer..  60. 2002
• Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging..  59. 2002
• Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer..  59. 2002
• Natural history of chronic renal insufficiency after partial and radical nephrectomy..  59. 2002
• Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor..  59. 2002
• Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience..  59. 2002
• Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up..  58. 2001
• Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis..  58. 2001
• Polypropylene sling for the treatment of stress urinary incontinence..  58. 2001
• Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin..  58. 2001
• Hand-assisted demucosalized gastrocystoplasty comparing different tissue closure methods..  58. 2001
• Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer..  58. 2001
• Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy..  58. 2001
• Nitric oxide synthase activity in human seminal plasma..  58. 2001
• Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma..  57. 2001
• Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia..  57. 2001
• Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy?.  57. 2001
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology..  57. 2001
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up..  57. 2001
• Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen..  57. 2001
• Primary genitourinary melanoma..  57. 2001
• Histologic effects of testicular sperm extraction on the testicle in men with nonobstructive azoospermia..  57. 2001
• Urodynamic pattern changes in multiple sclerosis..  57. 2001
• E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder..  57. 2001
• Is fascia lata allograft material trustworthy for pubovaginal sling repair?.  56. 2000
• Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder..  56. 2000
• Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy..  56. 2000
• Second primary malignancies associated with renal cell carcinoma: influence of histologic type..  56. 2000
• Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy..  56. 2000
• Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging..  56. 2000
• Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery..  55. 2000
• Laser-assisted demucosalized gastrocystoplasty with autoaugmentation in a canine model..  55. 2000
• Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial..  55. 2000
• Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection..  55. 2000
• Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial..  54. 1999
• Serum testosterone levels in African-American and white men undergoing prostate biopsy..  54. 1999
• Race is not an independent predictor of positive surgical margins after radical prostatectomy..  54. 1999
• Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL..  54. 1999
• Expression of vascular endothelial growth factor receptors in human prostate cancer..  54. 1999
• Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma..  54. 1999
• Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate..  53. 1999
• Comparison of absorbable and nonabsorbable sutures for microsurgical vasovasostomy in rats..  53. 1999
• Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?.  53. 1999
• Male urethral carcinoma: analysis of treatment outcome..  53. 1999
• Endoscopic surgery and telemedicine in microgravity: developing contingency procedures for exploratory class spaceflight..  53. 1999
• Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate..  53. 1999
• Near-infrared confocal laser scanning microscopy of bladder tissue in vivo..  53. 1999
• Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer..  53. 1999
• Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer..  53. 1999
• Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial..  53. 1999
• Effect of methylene blue, indigo carmine, and Renografin on human sperm motility..  53. 1999
• Recall and attitudes in patients with prostate cancer..  53. 1999
• Restoration of spermatogenesis after scrotal replacement of experimentally cryptorchid rat testis: assessment of germ cell apoptosis and eNOS expression..  53. 1999
• Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction..  52. 1998
• Increased incidence of depressive symptoms in men with erectile dysfunction..  52. 1998
• Testicular sperm extraction for nonobstructive azoospermia: results of a multibiopsy approach with optimized tissue dispersion..  52. 1998
• Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer..  52. 1998
• Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10..  52. 1998
• Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors..  52. 1998
• Impact of a clinical pathway for radical retropubic prostatectomy..  52. 1998
• Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost..  51. 1998
• Human sperm NADH and NADPH diaphorase cytochemistry: correlation with sperm motility..  51. 1998
• Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells..  51. 1998
• Assessment of the feasibility and impact of shared decision making in prostate cancer..  51. 1998
• Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group..  50. 1997
• Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection..  50. 1997
• Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination..  50. 1997
• Improved detection of recurrent bladder cancer using the Bard BTA stat Test..  50. 1997
• Reduction in testicular temperature after varicocelectomy in infertile men..  50. 1997
• Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer..  50. 1997
• Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma..  50. 1997
• Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder..  49. 1997
• Assessment of endpoints for clinical trials for localized prostate cancer..  49. 1997
• Assessment of hormone refractory prostate cancer..  49. 1997
• Planning controlled clinical trials. Prostatic cancer..  49. 1997
• Does current chemotherapy improve survival of patients with invasive bladder cancer?.  49. 1997
• Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers..  49. 1997
• Ileovesicostomy as an alternative form of bladder management in tetraplegic patients..  49. 1997
• Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia..  49. 1997
• Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy..  48. 1996
• Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies..  48. 1996
• Acid phosphatase: defining a role in androgen-independent prostate cancer..  47. 1996
• Routine CT scan in cystectomy patients: does it change management?.  47. 1996
• Surgical resection of brain metastases from renal cell carcinoma in 50 patients..  47. 1996
• A simplified method of epididymal sperm aspiration..  47. 1996
• Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation..  46. 1995
• Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?.  46. 1995
• Micropuncture retrieval of epididymal sperm with in vitro fertilization: importance of in vitro micromanipulation techniques..  46. 1995
• Laparoscopic laser-assisted bladder autoaugmentation..  46. 1995
• Distinguishing prognostic and treatment-predictive information for localized prostate cancer..  45. 1995
• Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy..  45. 1995
• Laser tissue welding in genitourinary reconstructive surgery: assessment of optimal suture materials..  45. 1995
• Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin..  44. 1994
• Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience..  44. 1994
• Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations..  43. 1994
• Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue culture..  43. 1994
• Heterogeneity of prostate cancer in radical prostatectomy specimens..  43. 1994
• Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy..  43. 1994
• Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination..  42. 1993
• Clinical experience with Mentor Alpha I inflatable penile prosthesis. Report on 333 cases..  42. 1993
• CO2 laser welding versus conventional microsuture repair in patch-graft urethroplasty..  41. 1993
• Surgical management of urethral strictures based on etiology. Where do urethral stents fit in?.  40. 1992
• Use of infra-pubic incision for insertion of Mentor Mark II inflatable penile prosthesis..  39. 1992
• Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy..  39. 1992
• Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy..  38. 1991
• Initial results with slightly modified Kock pouch..  37. 1991
• Management of penile gunshot wounds..  36. 1990
• Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia..  36. 1990
• Surgical treatment of brain metastases from renal cell carcinoma..  36. 1990
• Transrectal sonography for serial evaluation of prostatic malignancy..  36. 1990
• Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG..  34. 1989
• Method of circumferential pressure dressing of scrotum following bilateral orchiectomy..  33. 1989
• Thomas Hillier and percutaneous nephrostomy..  33. 1989
• Assessment of male infertility: correlation between results of semen analysis and phosphorus-31 magnetic resonance spectroscopy..  33. 1989
• Experience with potency preservation during radical prostatectomy. Significance of learning curve..  32. 1988
• Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial..  32. 1988
• The Kelly scrotal bridge..  31. 1988
• Cost-effectiveness of extracorporeal shock-wave lithotripsy..  31. 1988
• Correlation between intracavernous papaverine injection and Doppler analysis in impotent men..  30. 1987
• Octoson imaging in pediatric urology..  30. 1987
• Sonography in evaluation of carcinoma of bladder..  29. 1987
• Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer..  28. 1986
• Use of occlusion balloon catheter in percutaneous renal stone extraction..  27. 1986
• Consideration for treatment of upper urinary tract tumors with topical therapy..  26. 1985
• Gleason grading of prostate cancer: a predictor of survival..  25. 1985
• Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study..  25. 1985
• Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors..  25. 1985
• Interstitial radiation: short-term palliation or curative therapy?.  25. 1985
• Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy..  25. 1985
• Prostatic biopsy after irradiation therapy for prostatic cancer..  25. 1985
• Renal carbuncle: comparison between surgical open drainage and closed percutaneous drainage..  25. 1985
• Magnetic resonance imaging and its application in urology..  23. 1984
• Penile corporoplasty with polytetrafluoroethylene (PTFE) grafts..  22. 1983
• Impact of symptomatic interval on prognosis of patients with stage III testicular cancer..  21. 1983
• Lymphocele after pelvic lymphadenectomy for urologic cancer..  17. 1981
• Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation..  14. 1979
• Immunoglobulin A in split ejaculates of patients with prostatitis..  9. 1977
• Clinical use of immunoelectrophoresis of split ejaculates. I. Variation of patterns due to antisera..  9. 1977
• Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment..  6. 1975
• Sigmoid conduit urinary diversion..  6. 1975
• Metastatic carcinoma of prostate masquerading as abdominal aortic aneurysm..  5. 1975
• Renal function after ligation of right renal vein..  5. 1975
• Scrotal aspiration: aid in early differentiation between torsion of spermatic cord and acute epididymo-orchitis..  4. 1974
• Bedside sphincterometry..  4. 1974
• Acute urinary retention in a child due to procolpos and pyometrium..  3. 1974
• Flucytosine in urinary candida infections..  3. 1974
• Left spermatic vein cortisol in subfertile men with varicocele..  3. 1974
• Lipogranulomatosis of external genitalia..  3. 1974
• Erythromycin plus sodium bicarbonate in chronic bacterial prostatitis..  3. 1974
• Familial vesicoureteral reflux..  2. 1973
• Serum finding associated with carcinoma of kidney..  2. 1973
• Primary or pseudohyperparathyroidism?.  2. 1973
• Penile tuberculosis..  1. 1973
• Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2. 2021
• EDITORIAL COMMENT..  154. 2021
• AUTHOR REPLY..  146. 2020
• AUTHOR REPLY..  146. 2020
• AUTHOR REPLY..  144. 2020
• AUTHOR REPLY..  142. 2020
• AUTHOR REPLY..  138. 2020
• AUTHOR REPLY..  135. 2020
• AUTHOR REPLY..  135. 2020
• Pelvic Hematoma following Urolift Procedure for BPH..  137. 2019
• EDITORIAL COMMENT..  128. 2019
• Editorial Comment..  126. 2019
• EDITORIAL COMMENT..  124. 2019
• EDITORIAL COMMENT..  123. 2019
• Single-Port Robot-Assisted Radical Prostatectomy: First Clinical Experience Using The SP Surgical System..  124. 2018
• Author Reply..  108. 2017
• Editorial Comment..  102. 2016
• Editorial Comment..  102. 2016
• Editorial Comment..  102. 2016
• Editorial Comment..  99. 2016
• Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening..  95. 2016
• Author Reply..  91. 2016
• Reply to Letter to the Editor: Effect of Tadalafil Once Daily (OaD) on Penile Length Loss and Morning Erections in Patients Post Bilateral Nerve-sparing Radical Prostatectomy (nsRP): Results From a Randomized Controlled Trial (Urology 2015;85:1090-1096)..  86. 2015
• Reply: To PMID 26142590..  86. 2015
• Editorial comment..  85. 2015
• Reply: To PMID 25623680..  85. 2015
• Reply: To PMID 25623694..  85. 2015
• Reply by the authors..  84. 2014
• Editorial comment..  83. 2014
• Editorial comment..  83. 2014
• Editorial comment..  83. 2014
• Reply: To PMID 24094653..  82. 2013
• Reply by the authors..  82. 2013
• Reply by the authors..  82. 2013
• Reply: To PMID 23561709..  81. 2013
• Editorial comment..  81. 2013
• Editorial comment..  81. 2013
• Editorial comment..  79. 2012
• Editorial comment..  74. 2009
• Editorial comment. A new diagnosis of a small kidney tumor..  73. 2009
• Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number..  73. 2009
• Editorial comment..  73. 2009
• Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer..  58. 2001
• Editorial comment..  57. 2001
• Clinical states in prostate cancer: toward a dynamic model of disease progression..  55. 2000
• Prostatitis: myths and realities..  53. 1999
• Assisted reproduction cost-effectiveness analysis..  50. 1997
• Non-Hodgkin's lymphoma can mimic renal adenocarcinoma with inferior vena caval involvement..  43. 1994
• Semen quality and chronic abacterial prostatitis..  39. 1992
• Use of miconazole as bladder irrigant..  24. 1984
• Microsurgical reimplantation of amputated penis..  12. 1978
• Author Reply. 2022
• AUTHOR REPLY. 2019
• Author Reply. 2017
• AUTHOR REPLY TO COMMENTARY ON "INCIDENCE AND LONG-TERM OUTCOMES OF GENDER-AFFIRMING PHALLOPLASTY: ANALYSIS OF A LARGE STATEWIDE POPULATION-BASED DATASET". 2024
• Author Response: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis. 2024
• Re: Selective Serotonin Reuptake Inhibitor (SSRI) Use Is Not Associated With Impaired Semen Parameters. 2023
• A Thoughtful Pause for Sparing Oophorectomy. 2019
• Best practice policy statement on urologic surgery antimicrobial prophylaxis. 2009
• Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder Cancer..  130. 2019
• Editorial comment..  84. 2014
• Renal cryoablation: study with care--proceed with caution..  65. 2005
• Fresh testicular sperm from men with nonobstructive azoospermia works best for ICSI..  64. 2004
• Rationale for and results of nerve grafting during radical prostatectomy..  57. 2001
• Percent free prostate-specific antigen for first-time prostate biopsy..  57. 2001
• Optimizing Nonsurgical Treatments of Overactive Bladder in the United States. 2020
• Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysis. 2020
• Healthcare Costs of Post-Prostate Biopsy Sepsis. 2019
• A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. 2014
• A review of contemporary data on surgically resected renal masses--benign or malignant? 2013
• Complications associated with patient positioning in urologic surgery. 2010
• The genetic and phenotypic basis of infertility in men with pediatric urologic disorders. 2010
• No-scalpel, no-needle vasectomy. 2006
• DNA-based molecular cytology for bladder cancer surveillance. 2006
• The diagnosis and staging of bladder cancer: from RBCs to TURs. 2006
• Urothelial cancer biomarkers for detection and surveillance. 2006
• Significance of the polyglutamine tract polymorphism in the androgen receptor. 2001
• Gene therapy for prostate cancer. 2001
• Prostate-specific membrane antigen: present and future applications. 2000
• Plexiform neurofibroma involving the genitourinary tract in children: case reports and review of the literature. 1997
• Computer modeling in urology. 1996
• Hemospermia: diagnosis and management. 1995
• Nonseminomatous germ cell tumors of the testis: current concepts and controversies. 1994
• A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-Analysis. 2023
• Future of Male Infertility Evaluation and Treatment: Brief Review of Emerging Technology. 2022
• Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand? 2021
• Robotic One Access Surgery (R-1): Initial Preclinical Experience for Urological Surgeries. 2019
• What Is the Role of α-Blockers for Medical Expulsive Therapy? Results From a Meta-analysis of 60 Randomized Trials and Over 9500 Patients. 2018
• Histologic Inflammatory Response to Transvaginal Polypropylene Mesh: A Systematic Review. 2017
• Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review? 2016
• Subcutaneous cod liver oil injection for penile augmentation: review of literature and report of eight cases. 2010
• Laser tissue welding in urologic surgery. 1994

Identity

ISO Abbreviation

• Urology

Linking ISSN

• 0090-4295

International Standard Serial Number (ISSN)

• 0090-4295

Electronic International Standard Serial Number (EISSN)

• 1527-9995